Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 19 min ago
Peer-reviewedCC BYFrontiers in pharmacology

The role of sitagliptin in modifying metabolic, hormonal and clinical parameters in polycystic ovarian syndrome patients: a randomized controlled trial

  • Ahmed E. Altyar1
  • Dina Y. Dessouky2
  • Sara Abdallah Mohamed Salem3
  • Heba F. Salem4
  • Marian S. Boshra5
5 affiliations
  1. 1Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University , ,
  2. 2Department of Clinical Pharmacy, Cairo University Hospitals (Kasr Al Ainy), Cairo University , ,
  3. 3Department of Obstetrics and Gynecology, Faculty of Medicine, Beni-Suef University , ,
  4. 4Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University , ,
  5. 5Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University , ,
Read full textPDFCite

Related

  1. Effect of a free sugar-restricted diet on anthropometric parameters, lipid profile, and glycemic control in women with polycystic ovary syndrome: a randomized controlled trial.
    Hajar Gholamshahi, Alireza Houshdar Tehrani, Danial Fotros +1
    BMC endocrine disordersPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCPMC
  2. Disease-modifying therapies (DMTs) discontinuation in older relapsing-remitting multiple sclerosis (RRMS) patients with stable disease: Two-year randomized, controlled trial.
    Sajjad Daneshyar, Masoud Ghiasian, Salman Khazaei +2
    Caspian journal of internal medicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Effects of different exercise types on visceral adipose tissue and glycemic parameters in adults with stage 1 cardiovascular-kidney-metabolic syndrome: a systematic review and network meta-analysis of randomized controlled trials
    Xinda Wei, Hanyu Zhao, Shuang Yue +7
    Frontiers in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Efficacy of Disease-Modifying Treatments in Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-Analysis of Five Phase III Randomized Controlled Trials
    Y.-H. Hung, C.-H. Tsai, T.-W. Kao +6
    medRxivPreprintCC BY-NC-NDFull textCardiovascular medicinemedRxiv
  5. Combined cold atmospheric plasma and photobiomodulation is associated with improved early macroscopic and ultrasonographic wound-healing parameters after unilateral mastectomy in female dogs: an exploratory randomized intra-individual controlled clinical study.
    Guilherme Ramon Vieira da Silva, Márcio Santos de Oliveira Filho, Samuel Ferreira de França Silvestre +14
    BMC veterinary researchPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{altyar2026role,
  title = {{The role of sitagliptin in modifying metabolic, hormonal and clinical parameters in polycystic ovarian syndrome patients: a randomized controlled trial}},
  author = {Ahmed E. Altyar and Dina Y. Dessouky and Sara Abdallah Mohamed Salem and Heba F. Salem and Marian S. Boshra},
  journal = {Frontiers in pharmacology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13658494},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - The role of sitagliptin in modifying metabolic, hormonal and clinical parameters in polycystic ovarian syndrome patients: a randomized controlled trial
AU  - Ahmed E. Altyar
AU  - Dina Y. Dessouky
AU  - Sara Abdallah Mohamed Salem
AU  - Heba F. Salem
AU  - Marian S. Boshra
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in pharmacology
UR  - https://europepmc.org/article/PMC/PMC13658494
SN  - 1663-9812
ER  -